Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland

BACKGROUND: Pirfenidone and nintedanib are considered as the standard of care in idiopathic pulmonary fibrosis (IPF), but there is no consensus as to which of these two agents should be regarded as first-line treatment. OBJECTIVE: To provide real-world data on therapeutic decisions of pulmonary spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Górska, Katarzyna, Maskey-Warzęchowska, Marta, Barnaś, Małgorzata, Białas, Adam, Barczyk, Adam, Jagielska-Len, Hanna, Jassem, Ewa, Kania, Aleksander, Lewandowska, Katarzyna, Majewski, Sebastian, Martusewicz-Boros, Magdalena M., Piotrowski, Wojciech J., Siemińska, Alicja, Sładek, Krzysztof, Sobiecka, Małgorzata, Trzaska-Sobczak, Marzena, Tomkowski, Witold, Żołnowska, Beata, Krenke, Rafał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425901/
https://www.ncbi.nlm.nih.gov/pubmed/36052286
http://dx.doi.org/10.1177/20406223221117982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425901/
https://www.ncbi.nlm.nih.gov/pubmed/36052286
http://dx.doi.org/10.1177/20406223221117982

Ejemplares similares